NCT04942808

Brief Summary

The goal is to evaluate, after 5 to 8 years, the marginal bone loss around tissue-level implants and bone-level implants in patients who have not followed the maintenance program. Medical records of patients who have been implanted for at least 5 to 8 years and who have been lost during this period are collected from three private clinics in Beirut,Lebanon and the Saint Joseph University Health Center in Beirut,Lebanon. On an individual sheet, the patient as well as the implants data will be noted. Patients will be called for reevaluation after 5-8 years. After signing the informed consent, the measurements by a PCP-15 probe of the plaque index (FMPS) and the bleeding index (FMBS) as well as the height of the keratinized tissue are indicated on the sheet. If the smoking status has changed, this will be mentioned too. The marginal bone loss will be measured on the X-rays taken immediately after the implant placement, after 1 year of loading and then at the reevaluation session.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
130

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

June 16, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 28, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 29, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 29, 2022

Completed
Last Updated

June 28, 2021

Status Verified

June 1, 2021

Enrollment Period

12 months

First QC Date

June 16, 2021

Last Update Submit

June 25, 2021

Conditions

Keywords

Oral hygieneDental implantPeriodontal maintenanceMarginal bone lossTissue level implantBone level implantInternal connectionExternal connection

Outcome Measures

Primary Outcomes (2)

  • Marginal bone loss

    It will be measured mesially and distally on each implant platform until the bone's first coronal contact with the implant. Then, the total bone loss on each implant will be calculated. This is done on the software in millimeters.

    5 to 8 years

  • Level of oral hygiene

    The second factor studied is the level of hygiene which will be calculated by measuring the plaque index and bleeding on probing. This is done with a PCP-15 periodontal probe by a light sweeping movement at the level of the 4 sites of each tooth and implant and then written on the personalized card for each patient.

    5 to 8 years

Secondary Outcomes (8)

  • Smoking status

    5 to 8 years

  • Periodontal status

    5 to 8 years

  • success and survival of the implant

    5 to 8 years

  • Years in function

    5 to 8 years

  • Height and thickness of the peri-implant keratinized mucosa

    5 to 8 years

  • +3 more secondary outcomes

Other Outcomes (5)

  • Implant position

    5 to 8 years

  • Type of prosthesis

    5 to 8 years

  • Surgical times

    5 to 8 years

  • +2 more other outcomes

Interventions

Periapical radiographs on reevaluation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients who had implants between 2012 and 2015 and who did not follow a maintenance program and whose inclusion criteria are present will be included in the study.

You may qualify if:

  • Patients who have undergone the initial phase followed by implant placement in the posterior region.
  • Implants placed for more than 5 years.
  • The implant systems selected are:
  • Tissue Level Implants: Straumann (Straumann Dental Implants System, Switzerland),
  • Bone Level implants: Branemark, 3i Biomet (external and internal connection), Nobel replace and Astra.
  • Patients who did not comply with the maintenance program and who missed more than 30% of appointments.

You may not qualify if:

  • Systemic diseases (uncontrolled diabetes, drugs which may affect bone metabolism).
  • Totally edentulous.
  • Severe periodontitis not stabilized
  • Inappropriate, unavailable or distorted x-rays.
  • Augmented sites.
  • Implants placed at a supra or infraosseous level.
  • Implants placed immediately after extraction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saint Joseph University of Beirut

Beirut, Mount Lebanon, Lebanon

RECRUITING

MeSH Terms

Conditions

Peri-Implantitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Central Study Contacts

Layal Bou Semaan, DDS

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident

Study Record Dates

First Submitted

June 16, 2021

First Posted

June 28, 2021

Study Start

June 1, 2021

Primary Completion

May 29, 2022

Study Completion

July 29, 2022

Last Updated

June 28, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF

Locations